Quantum Immunologics, Inc.

Quantum Immunologics, Inc. (Quantum Immunologics) is a privately held pharmaceutical company, engaged in the development and distribution of novel advanced level products for the treament of therapeutic diseases. The company is focused on the research and clinical trials of its three product lines which includes individualized cancer immunotherapy system with OFA/iLRP as its target product as it has been identified in all human with murine cancers examined and includes myeloid and lymphoid leukemias, lymphomas, renal cell carcinomas, prostate cancer, breast cancer, lung cancer, melanoma, squamous cell carcinoma, and ovarian cancer; Cancer Monitoring Test monitors blood levels of the immune response in a patient following treatment and can be used to monitor the remission process to ensure the vaccine safety; and Cancer Screening Test is an extention of Monitoring test requires further clinical trials and documentation. Quantum Immunologics is headquartered at Tampa, Florida, the US.